DARATUMUMAB
| Source | Section 100 (CT) | 
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | 
| 
                        
                         | 
                  
| 
                        
                         | 
                  
| Code & Prescriber | 
                     Medicinal Product Pack (Name, form & strength and pack size)  | 
                  Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge | 
|---|---|---|---|---|---|---|---|
| 12682LMP | DARATUMUMAB daratumumab 1.8 g/15 mL injection, 15 mL vial (PI, CMI)  | 
                  1 | 1 | 5 | $7010.28 | $31.60 | $31.60 | 
| Available brands | |||||||
| Darzalex SC | 
- Legend
 - MPMedical Practitioner
 




